Dimethyl Fumarate Treatment Is Ineffective for Primary Progressive MS
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Neurology(R) Neuroimmunology & Neuroinflammation
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Dimethyl Fumarate Treatment in Patients With Primary Progressive Multiple Sclerosis: A Randomized, Controlled Trial
Neurol Neuroimmunol Neuroinflamm 2021 Sep 01;8(5)e1037, H Højsgaard Chow, J Talbot, H Lundell, C Gøbel Madsen, L Marstrand, T Lange, MR Mahler, S Buhelt, R Holm Hansen, M Blinkenberg, J Romme Christensen, P Soelberg Sørensen, M Rode von Essen, HR Siebner, F SellebjergFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.